{"id":37131,"date":"2026-03-23T13:20:15","date_gmt":"2026-03-23T13:20:15","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/37131\/"},"modified":"2026-03-23T13:20:15","modified_gmt":"2026-03-23T13:20:15","slug":"roche-pharma-commits-1-5-billion-swiss-franc-investment-in-india-over-next-five-years-etpharma","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/37131\/","title":{"rendered":"Roche Pharma commits 1.5 billion Swiss franc investment in India over next five years, ETPharma"},"content":{"rendered":"

\"\"\/New Delhi: Swiss healthcare major Roche Pharma<\/a> is committing to invest 1.5 billion Swiss Franc<\/a> in India over the next five years, a senior company executive said on Wednesday.<\/p>\n

Speaking at the India-European Free Trade Association (EFTA)<\/a> Prosperity Summit here, Roche<\/a> Pharma Area Head CEETRIS (Central Eastern Europe, Turkiye, Russia and Indian Subcontinent) Francois du Toit<\/a> said the company’s investment underlines a long-term commitment to the Indian market.<\/p>\n

“We currently have over 5,000 employees in India. We commit to investing 1.5 billion Swiss Francs at a minimum into our core businesses over the next five years,” du Toit<\/a> said.<\/p>\n

The company sees India not only as an important market, but also as a hub for innovation, he added.<\/p>\n

The company’s investment will go into three critical areas, including R&D<\/a>, he said.<\/p>\n

Roche<\/a> would also be working with Ayushman Bharat<\/a> and several other schemes to bring its innovative products to as many patients in India as possible, he added.<\/p>\n

India’s free trade agreement (FTA) with the four-nation bloc, the European Free Trade Association (EFTA), comes into effect from Wednesday.\n <\/p>\n

Published On Oct 3, 2025 at 01:39 PM IST<\/p>\n

\n Join the community of 2M+ industry professionals.
\n Subscribe to Newsletter to get latest insights & analysis in your inbox.\n <\/p>\n

All about ETPharma industry right on your smartphone! <\/p>\n

\"\"\/ <\/p>\n","protected":false},"excerpt":{"rendered":"New Delhi: Swiss healthcare major Roche Pharma is committing to invest 1.5 billion Swiss Franc in India over…\n","protected":false},"author":2,"featured_media":37132,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[4127,5496,5495,251,134,5497,470,5498],"class_list":{"0":"post-37131","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-ayushman-bharat","9":"tag-india-european-free-trade-association-efta","10":"tag-investment-in-india","11":"tag-rd","12":"tag-roche","13":"tag-roche-pharma","14":"tag-swiss-franc","15":"tag-toit"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116278697884767135","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/37131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=37131"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/37131\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/37132"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=37131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=37131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=37131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}